Viveve Medical, Inc. (VIVE)
USD 0.0
(100.0%)
USD 0.0
(100.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2021 | -22.02 Million USD | -7.46% |
| 2020 | -21.23 Million USD | 54.54% |
| 2019 | -46.71 Million USD | 5.01% |
| 2018 | -49.18 Million USD | -34.27% |
| 2017 | -36.63 Million USD | -82.14% |
| 2016 | -20.11 Million USD | -61.85% |
| 2015 | -12.42 Million USD | -101.07% |
| 2014 | -6.18 Million USD | -276.62% |
| 2013 | 3.49 Million USD | 141.72% |
| 2012 | -8.38 Million USD | -45.66% |
| 2011 | -5.75 Million USD | -1040.2% |
| 2010 | -505 Thousand USD | 68.94% |
| 2009 | -1.62 Million USD | 16.19% |
| 2008 | -1.94 Million USD | 18.04% |
| 2007 | -2.36 Million USD | -279.45% |
| 2006 | 1.31 Million USD | 204.02% |
| 2005 | -1.26 Million USD | -52.22% |
| 2004 | -833 Thousand USD | -261.12% |
| 2003 | 517 Thousand USD | 69.51% |
| 2002 | 305 Thousand USD | 107.82% |
| 2001 | -3.9 Million USD | 47.34% |
| 2000 | -7.41 Million USD | -13.04% |
| 1999 | -6.55 Million USD | 60.51% |
| 1998 | -16.6 Million USD | -15.28% |
| 1997 | -14.4 Million USD | -860.0% |
| 1996 | -1.5 Million USD | -175.0% |
| 1995 | 2 Million USD | 176.92% |
| 1994 | -2.6 Million USD | 35.0% |
| 1993 | -4 Million USD | 85.77% |
| 1992 | -28.1 Million USD | -1121.74% |
| 1991 | -2.3 Million USD | -2200.0% |
| 1990 | -100 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 Q3 | -5.29 Million USD | 13.6% |
| 2022 Q2 | -6.12 Million USD | 0.87% |
| 2022 Q1 | -6.17 Million USD | 2.39% |
| 2021 Q2 | -4.05 Million USD | 30.06% |
| 2021 Q3 | -5.85 Million USD | -44.64% |
| 2021 Q4 | -6.32 Million USD | -8.02% |
| 2021 FY | -22.82 Million USD | -7.46% |
| 2021 Q1 | -5.79 Million USD | -21.79% |
| 2020 Q3 | -3.73 Million USD | 47.51% |
| 2020 Q1 | -6.31 Million USD | 57.41% |
| 2020 Q2 | -7.11 Million USD | -12.76% |
| 2020 Q4 | -4.75 Million USD | -27.31% |
| 2020 FY | -21.23 Million USD | 54.54% |
| 2019 Q3 | -7.95 Million USD | 18.18% |
| 2019 Q1 | -10.02 Million USD | 25.67% |
| 2019 Q4 | -14.81 Million USD | -86.24% |
| 2019 Q2 | -9.72 Million USD | 3.04% |
| 2019 FY | -46.71 Million USD | 5.01% |
| 2018 Q3 | -12.3 Million USD | -6.84% |
| 2018 Q1 | -12.66 Million USD | -23.91% |
| 2018 Q2 | -11.51 Million USD | 9.1% |
| 2018 FY | -49.18 Million USD | -34.27% |
| 2018 Q4 | -13.49 Million USD | -9.66% |
| 2017 Q1 | -6.69 Million USD | -15.03% |
| 2017 FY | -36.63 Million USD | -82.14% |
| 2017 Q4 | -10.22 Million USD | -6.33% |
| 2017 Q3 | -9.61 Million USD | 7.77% |
| 2017 Q2 | -10.42 Million USD | -55.71% |
| 2016 Q3 | -4.86 Million USD | 8.41% |
| 2016 Q4 | -5.82 Million USD | -19.53% |
| 2016 Q1 | -4.1 Million USD | -11.67% |
| 2016 Q2 | -5.31 Million USD | -29.47% |
| 2016 FY | -20.11 Million USD | -61.85% |
| 2015 Q2 | -3 Million USD | -19.1% |
| 2015 Q3 | -3.21 Million USD | -7.09% |
| 2015 Q1 | -2.52 Million USD | -44.84% |
| 2015 FY | -12.42 Million USD | -101.07% |
| 2015 Q4 | -3.67 Million USD | -14.23% |
| 2014 Q3 | -2.5 Million USD | -207.52% |
| 2014 FY | -6.18 Million USD | -276.62% |
| 2014 Q1 | -2.41 Million USD | -160.73% |
| 2014 Q2 | 2.32 Million USD | 196.56% |
| 2014 Q4 | -1.74 Million USD | 30.41% |
| 2013 Q3 | -609 Thousand USD | -107.66% |
| 2013 Q1 | -7.8 Million USD | -360.18% |
| 2013 FY | 3.49 Million USD | 141.72% |
| 2013 Q4 | 3.97 Million USD | 752.22% |
| 2013 Q2 | 7.94 Million USD | 201.77% |
| 2012 Q3 | -3.16 Million USD | -119.18% |
| 2012 Q2 | -1.44 Million USD | 78.7% |
| 2012 Q1 | -6.77 Million USD | -558.79% |
| 2012 FY | -8.38 Million USD | -45.66% |
| 2012 Q4 | 3 Million USD | 194.82% |
| 2011 Q4 | -1.02 Million USD | -156.61% |
| 2011 FY | -5.75 Million USD | -1040.2% |
| 2011 Q2 | -541 Thousand USD | 85.71% |
| 2011 Q1 | -3.78 Million USD | -1556.54% |
| 2011 Q3 | -401 Thousand USD | 25.88% |
| 2010 FY | -505 Thousand USD | 68.94% |
| 2010 Q3 | -5000.00 USD | 97.49% |
| 2010 Q1 | -561 Thousand USD | 6.97% |
| 2010 Q2 | -199 Thousand USD | 64.53% |
| 2010 Q4 | 260 Thousand USD | 5300.0% |
| 2009 Q3 | -358 Thousand USD | -16.61% |
| 2009 Q1 | -358 Thousand USD | -61.26% |
| 2009 Q4 | -603 Thousand USD | -68.44% |
| 2009 FY | -1.62 Million USD | 16.19% |
| 2009 Q2 | -307 Thousand USD | 14.25% |
| 2008 Q1 | -762 Thousand USD | 6.96% |
| 2008 FY | -1.94 Million USD | 18.04% |
| 2008 Q4 | -222 Thousand USD | 22.11% |
| 2008 Q3 | -285 Thousand USD | 57.53% |
| 2008 Q2 | -671 Thousand USD | 11.94% |
| 2007 FY | -2.36 Million USD | -279.45% |
| 2007 Q4 | -819 Thousand USD | -64.13% |
| 2007 Q2 | -363 Thousand USD | 47.08% |
| 2007 Q1 | -686 Thousand USD | -2005.56% |
| 2007 Q3 | -499 Thousand USD | -37.47% |
| 2006 Q2 | 72 Thousand USD | -94.42% |
| 2006 FY | 1.31 Million USD | 204.02% |
| 2006 Q1 | 1.29 Million USD | 425.19% |
| 2006 Q4 | 36 Thousand USD | 145.0% |
| 2006 Q3 | -80 Thousand USD | -211.11% |
| 2005 FY | -1.26 Million USD | -52.22% |
| 2005 Q4 | -397 Thousand USD | 0.0% |
| 2005 Q3 | -397 Thousand USD | -36.9% |
| 2005 Q1 | -184 Thousand USD | -190.2% |
| 2005 Q2 | -290 Thousand USD | -57.61% |
| 2004 Q3 | -436 Thousand USD | -73.71% |
| 2004 Q2 | -251 Thousand USD | 28.29% |
| 2004 Q1 | -350 Thousand USD | -572.97% |
| 2004 FY | -833 Thousand USD | -261.12% |
| 2004 Q4 | 204 Thousand USD | 146.79% |
| 2003 Q2 | 203 Thousand USD | 1253.33% |
| 2003 FY | 517 Thousand USD | 69.51% |
| 2003 Q3 | 225 Thousand USD | 10.84% |
| 2003 Q4 | 74 Thousand USD | -67.11% |
| 2003 Q1 | 15 Thousand USD | -92.86% |
| 2002 Q4 | 210 Thousand USD | -4.11% |
| 2002 FY | 305 Thousand USD | 107.82% |
| 2002 Q3 | 219 Thousand USD | 62.22% |
| 2002 Q2 | 135 Thousand USD | 152.12% |
| 2002 Q1 | -259 Thousand USD | 56.69% |
| 2001 Q4 | -598 Thousand USD | 39.47% |
| 2001 Q3 | -988 Thousand USD | 13.33% |
| 2001 Q2 | -1.14 Million USD | 3.06% |
| 2001 Q1 | -1.17 Million USD | 61.16% |
| 2001 FY | -3.9 Million USD | 47.34% |
| 2000 Q1 | -2.18 Million USD | -73.94% |
| 2000 Q2 | -882 Thousand USD | 59.6% |
| 2000 Q3 | -1.31 Million USD | -49.32% |
| 2000 Q4 | -3.02 Million USD | -129.92% |
| 2000 FY | -7.41 Million USD | -13.04% |
| 1999 Q4 | -1.25 Million USD | 10.36% |
| 1999 Q3 | -1.4 Million USD | 17.65% |
| 1999 Q2 | -1.7 Million USD | 22.73% |
| 1999 Q1 | -2.2 Million USD | 33.33% |
| 1999 FY | -6.55 Million USD | 60.51% |
| 1998 Q1 | -3.9 Million USD | 23.53% |
| 1998 Q3 | -4 Million USD | 25.93% |
| 1998 Q4 | -3.3 Million USD | 17.5% |
| 1998 FY | -16.6 Million USD | -15.28% |
| 1998 Q2 | -5.4 Million USD | -38.46% |
| 1997 Q2 | -2.7 Million USD | 10.0% |
| 1997 Q3 | -3.6 Million USD | -33.33% |
| 1997 FY | -14.4 Million USD | -860.0% |
| 1997 Q1 | -3 Million USD | -130.77% |
| 1997 Q4 | -5.1 Million USD | -41.67% |
| 1996 Q1 | 1.3 Million USD | -59.38% |
| 1996 Q4 | -1.3 Million USD | -116.67% |
| 1996 Q3 | -600 Thousand USD | 33.33% |
| 1996 Q2 | -900 Thousand USD | -169.23% |
| 1996 FY | -1.5 Million USD | -175.0% |
| 1995 Q2 | -600 Thousand USD | -400.0% |
| 1995 Q3 | -800 Thousand USD | -33.33% |
| 1995 Q4 | 3.2 Million USD | 500.0% |
| 1995 Q1 | 200 Thousand USD | 150.0% |
| 1995 FY | 2 Million USD | 176.92% |
| 1994 Q1 | -700 Thousand USD | 22.22% |
| 1994 FY | -2.6 Million USD | 35.0% |
| 1994 Q3 | -900 Thousand USD | -50.0% |
| 1994 Q4 | -400 Thousand USD | 55.56% |
| 1994 Q2 | -600 Thousand USD | 14.29% |
| 1993 Q4 | -900 Thousand USD | 0.0% |
| 1993 FY | -4 Million USD | 85.77% |
| 1993 Q1 | -900 Thousand USD | 10.0% |
| 1993 Q2 | -1.3 Million USD | -44.44% |
| 1993 Q3 | -900 Thousand USD | 30.77% |
| 1992 Q4 | -1 Million USD | 0.0% |
| 1992 Q1 | -25.1 Million USD | -4083.33% |
| 1992 Q3 | -1 Million USD | -11.11% |
| 1992 Q2 | -900 Thousand USD | 96.41% |
| 1992 FY | -28.1 Million USD | -1121.74% |
| 1991 Q4 | -600 Thousand USD | 0.0% |
| 1991 Q2 | -600 Thousand USD | -20.0% |
| 1991 Q3 | -600 Thousand USD | 0.0% |
| 1991 Q1 | -500 Thousand USD | 0.0% |
| 1991 FY | -2.3 Million USD | -2200.0% |
| 1990 FY | -100 Thousand USD | 0.0% |
| 1990 Q3 | - USD | 0.0% |
| 1990 Q2 | - USD | 100.0% |
| 1990 Q1 | -100 Thousand USD | 0.0% |
| 1990 Q4 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -81.66 Million USD | 73.027% |
| Cerus Corporation | -37.48 Million USD | 41.244% |
| OrthoPediatrics Corp. | -20.97 Million USD | -5.021% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -101.063% |
| Talis Biomedical Corporation | -62 Million USD | 64.477% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | -62.166% |
| Inogen, Inc. | -102.44 Million USD | 78.5% |
| Spectral AI, Inc. | -20.85 Million USD | -5.625% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 63.757% |
| CVRx, Inc. | -41.19 Million USD | 46.535% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 3540.665% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -148.893% |
| Orthofix Medical Inc. | -151.39 Million USD | 85.451% |
| Venus Concept Inc. | -37.25 Million USD | 40.867% |
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 64.252% |
| Bioventus Inc. | -156.23 Million USD | 85.901% |
| BrainsWay Ltd. | -4.19 Million USD | -424.827% |
| Envoy Medical, Inc. | -29.9 Million USD | 26.351% |
| electroCore, Inc. | -18.83 Million USD | -16.953% |
| IceCure Medical Ltd | -14.65 Million USD | -50.334% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 58.176% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | -60.252% |
| MaxCyte, Inc. | -37.92 Million USD | 41.917% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | -85.733% |
| Nexalin Technology, Inc. | -4.64 Million USD | -373.83% |
| PAVmed Inc | -64.17 Million USD | 65.677% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 58.017% |
| RxSight, Inc. | -48.6 Million USD | 54.684% |
| Sight Sciences, Inc. | -55.54 Million USD | 60.345% |
| SI-BONE, Inc. | -43.33 Million USD | 49.172% |
| TELA Bio, Inc. | -46.66 Million USD | 52.797% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 62.69% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 55.525% |
| LivaNova PLC | 17.54 Million USD | 225.539% |
| 908 Devices Inc. | -36.39 Million USD | 39.485% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 88.198% |
| Nemaura Medical Inc. | -14.14 Million USD | -55.737% |
| NeuroPace, Inc. | -32.95 Million USD | 33.162% |
| LENSAR, Inc. | -14.38 Million USD | -53.146% |
| Apyx Medical Corporation | -18.71 Million USD | -17.71% |
| Cutera, Inc. | -162.83 Million USD | 86.473% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | -103.389% |
| BioSig Technologies, Inc. | -29.04 Million USD | 24.152% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 73.355% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 0.281% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 132.516% |
| Axonics, Inc. | -6.08 Million USD | -261.81% |
| Outset Medical, Inc. | -172.79 Million USD | 87.253% |
| IRIDEX Corporation | -9.57 Million USD | -130.167% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 79.2% |
| IRadimed Corporation | 17.19 Million USD | 228.118% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -167.188% |
| INVO Bioscience, Inc. | -8.03 Million USD | -174.151% |
| Telesis Bio, Inc. | -47.72 Million USD | 53.845% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 315.044% |
| Varex Imaging Corporation | -47.7 Million USD | 53.822% |
| Quipt Home Medical Corp. | -2.78 Million USD | -691.2% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -95.171% |
| Pulmonx Corporation | -60.84 Million USD | 63.797% |
| Dynatronics Corporation | -2.69 Million USD | -716.505% |
| Modular Medical, Inc. | -17.47 Million USD | -26.085% |
| ReShape Lifesciences Inc. | -11.38 Million USD | -93.44% |
| Semler Scientific, Inc. | 20.58 Million USD | 207.015% |
| InMode Ltd. | 197.91 Million USD | 111.129% |
| Bruker Corporation | 427.2 Million USD | 105.156% |
| Cytosorbents Corporation | -28.5 Million USD | 22.732% |
| DexCom, Inc. | 541.5 Million USD | 104.068% |
| Align Technology, Inc. | 445.05 Million USD | 104.949% |
| ZimVie Inc. | -393.28 Million USD | 94.399% |
| Movano Inc. | -29.28 Million USD | 24.779% |
| Cytek Biosciences, Inc. | -12.14 Million USD | -81.322% |
| Nexalin Technology, Inc. | -4.64 Million USD | -373.83% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 3540.665% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 90.105% |
| Profound Medical Corp. | -28.56 Million USD | 22.899% |
| Insulet Corporation | 206.3 Million USD | 110.677% |
| enVVeno Medical Corporation | -23.51 Million USD | 6.332% |
| Surmodics, Inc. | -11.54 Million USD | -90.842% |
| iCAD, Inc. | -4.84 Million USD | -354.446% |
| Nuwellis, Inc. | -20.2 Million USD | -8.996% |
| Biotricity, Inc. | -14.09 Million USD | -56.283% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 82.151% |
| Aethlon Medical, Inc. | -12.2 Million USD | -80.428% |
| InspireMD, Inc. | -19.91 Million USD | -10.6% |
| PAVmed Inc. | -64.17 Million USD | 65.677% |
| BIOLASE, Inc. | -20.63 Million USD | -6.761% |
| Beyond Air, Inc. | -60.24 Million USD | 63.436% |
| FONAR Corporation | 10.56 Million USD | 308.443% |
| AxoGen, Inc. | -21.71 Million USD | -1.432% |
| Vivani Medical, Inc. | -25.65 Million USD | 14.131% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 177.247% |
| Inari Medical, Inc. | -1.63 Million USD | -1246.394% |
| UFP Technologies, Inc. | 44.92 Million USD | 149.032% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -329.181% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -233.479% |
| Tenon Medical, Inc. | -15.58 Million USD | -41.371% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | -42.791% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 37.659% |
| AdaptHealth Corp. | -678.89 Million USD | 96.755% |
| Sintx Technologies, Inc. | -8.25 Million USD | -166.703% |
| NanoVibronix, Inc. | -3.71 Million USD | -493.56% |
| Quanterix Corporation | -32.33 Million USD | 31.877% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -95.171% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 4641.649% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 92.819% |
| TransMedics Group, Inc. | -25.02 Million USD | 11.991% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 0.479% |
| NeuroMetrix, Inc. | -6.52 Million USD | -237.347% |
| Hyperfine, Inc. | -44.23 Million USD | 50.208% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 71.941% |
| Biomerica, Inc. | -5.97 Million USD | -268.468% |
| Bone Biologics Corporation | -8.94 Million USD | -146.147% |
| AVITA Medical, Inc. | -39.16 Million USD | 43.763% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -121.29% |
| Silk Road Medical, Inc | -55.74 Million USD | 60.485% |